CNTN1 and chronic inflammatory demyelinating polyradiculoneuropathy: As for other nodal/paranodal antibodies, anti-CNTN1 antibodies were detected in 6% of CIDP patients in whom advanced age, predominant motor involvement, aggressive symptom onset, and early axonal involvement were commonly observed (8–10).